High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers

Neoplasma

Volumn 57, Issue 3, 2010, Pages 247-252

  Yu, B ^a,b   Yang, H ^a,b   Zhang, C ^a   Wu, Q ^a   Shao, Y ^a,b   Zhang, J ^b   Guan, M ^e   Wan, J ^a,d   Zhang, W ^c,d  

^a Biomedical Research Institute   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c JINAN UNIVERSITY   (China)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^e FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Gastric cancer; HRM; Methylation; Pancreatic cancer; PCDH10

Indexed keywords

CELL ADHESION MOLECULE; PROTOCADHERIN 10; UNCLASSIFIED DRUG; CADHERIN; PCDH10 PROTEIN, HUMAN;

ARTICLE; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIGENETICS; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METHYLATION; SENSITIVITY ANALYSIS; STOMACH CANCER; COLORECTAL TUMOR; DNA METHYLATION; FREEZING; GENETICS; PANCREAS TUMOR; PATHOLOGY; STOMACH TUMOR;

CADHERINS; COLORECTAL NEOPLASMS; DNA METHYLATION; FREEZING; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 77954629208     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_03_247     Document Type: Article

References (31)

1. HIRANO S., SUZUKI ST., REDIES, C. The cadherin superfamily in neural development: diversity, function and interaction with other molecules. Front Biosci 2003; 8: d306-355. doi:10.2741/972
2. WU Q. MANIATIS TA. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 1999; 97: 779-790. doi:10.1016/S0092-8674(00)80789-8
3. PHILLIPS GR., TANAKA H., FRANK M., ELSTE A., FIDLER L. et al. Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons. J Neurosci 2003; 23: 5096-5104.
4. YAMAGATA K., ANDREASSON KI., SUGIURA H., MARU E., Dominique M. et al. F. Arcadlin is a neural activity-regulated cadherin involved in long term potentiation. J Biol Chem 1999; 274: 19473-11979. doi:10.1074/jbc.274.27.19473
5. HIRANO S., YAN Q., SUZUKI ST. Expression of a novel protocadherin, OL-protocadherin, in a subset of functional systems of the developing mouse brain. J Neurosci 1999; 19: 995-1005.
6. AOKI E., KIMURA R., SUZUKI ST., HIRANO S. Distribution of OL-protocadherin protein in correlation with specific neural compartments and local circuits in the postnatal mouse brain. Neuroscience 2003; 117: 593-614. doi:10.1016/S0306-4522(02)00944-2
7. MULLER K., HIRANO S., PUELLES L., REDIES C. OL-protocadherin expression in the visual system of the chicken embryo. J Comp Neurol 2004; 470: 240-255. doi:10.1002/cne.11044
8. NAKAO S., UEMURA M., AOKI E., SUZUKI ST., TAKEICHI M. et al. Distribution of OL-protocadherin in axon fibers in the developing chick nervous system. Brain Res Mol Brain Res 2005; 134: 294-308. doi:10.1016/j.molbrainres.2004.11.017
9. WOLVERTON T. Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 2001; 76: 66-72. doi:10.1006/geno.2001.6592
10. YING J., LI H., SENG TJ., LANGFORD C., SRIVASTAVA G. et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006; 25: 1070-1080. doi:10.1038/sj.onc.1209154
11. ESTELLER M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8: 286-298. doi:10.1038/nrg2005
12. ROSENBAUER F., OWENS BM., YU L., TUMANG JR., STEIDL U. et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat Genet 2006; 38: 27-37. doi:10.1038/ng1679
13. YU L., LIU C., VANDEUSEN J., BECKNELL B., DAI Z. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet 2005; 37: 265-274. doi:10.1038/ng1521
14. YU J., CHENG YY., TAO Q., CHEUNG KF., LAM CN. et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2009; 136: 640-651 e641.
15. YING J., GAO Z., LI H., SRIVASTAVA G., MURRAY PG. et al. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br J Haematol 2007; 136: 829-832. doi:10.1111/j.1365-2141.2007.06512.x
16. WOJDACZ TK., DOBROVIC A., HANSEN, LL. Methylation-sensitive high-resolution melting. Nat Protoc 2008; 3: 1903-1908. doi:10.1038/nprot.2008.191
17. VIRMANI AK., TSOU JA., SIEGMUND KD., SHEN LY., LONG TI. et al. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Cancer Epidemiol Biomarkers Prev 2002; 11: 291-297.
18. WITTWER CT., REED GH., GUNDRY CN., VANDERSTEEN JG., PRYOR, R. J. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003; 49: 853-860. doi:10.1373/49.6.853
19. PAZ MF., FRAGA MF., AVILA S., GUO M., POLLAN M. et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003; 63: 1114-1121.
20. CAMERON EE., BAYLIN SB., HERMAN JG. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 1999; 94: 2445-2451.
21. HSIEH CL. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994; 14: 5487-5494.
22. TABACK B., GIULIANO AE., LAI R., HANSEN N., SINGER FR. et al. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. Ann N Y Acad Sci 2006; 1075: 211-221. doi:10.1196/annals.1368.029
23. LIVAK KJ. SCHMITTGEN TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 2001; 25: 402-408.
24. SCHMITTGEN TD. LIVAK K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108. doi:10.1038/nprot.2008.73
25. HERMAN JG., GRAFF JR., MYOHANEN S., NELKIN BD., BAYLIN SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93: 9821-9826. doi:10.1073/pnas.93.18.9821
26. CLARK SJ., HARRISON J., PAUL C. L., FROMMER, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-2997. doi:10.1093/nar/22.15.2990
27. FROMMER M., MCDONALD LE., MILLAR DS., COLLIS CM., WATT F. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992; 89: 1827-1831. doi:10.1073/pnas.89.5.1827
28. COLELLA S., SHEN L., BAGGERLY KA., ISSA JP., KRAHE R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 2003; 35: 146-150.
29. WARNECKE PM., STIRZAKER C., MELKI JR., MILLAR DS., PAUL CL. et al. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997; 25: 4422-4426. doi:10.1093/ nar/25.21.4422
30. WOJDACZ TK. HANSEN LL. Reversal of PCR bias for improved sensitivity of the DNA methylation melting curve assay. Biotechniques 2006; 41: 274-278. doi:10.2144/000112240
31. KWABI-ADDO B., CHUNG W., SHEN L., ITTMANN M., WHEELER T. et al. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 2007; 13: 3796-3802. doi:10.1158/1078-0432.CCR-07-0085